Massive blood transfusion is associated with a wide range of adverse effects, some of which are understood, but controversy surrounds the effects of massive blood loss and transfusion on haemostasis and oxygen transport. Until we have a better understanding of the underlying pathophysiology and while storage of blood remains imperfect, there is a good case for the empirical use of super-fresh blood in this clinical setting. A practical approach to the exsanguinated patient is presented.
INTRODUCTION
Blood transfusion is basically intended to replace a physiological deficiency and in most situations entails replacement with red blood cells of varying size, number and function along with a paucity of other blood components grossly depleted in quantity and function. With an increasing awareness of cost and wastage we no longer think of blood transfusion purely in terms of volume replacement with whole blood but more as specifically indicated blood component therapy. The use of blood component therapy in the context of massive blood transfusion is controversial and it is the authors' aim to review this field in which much of the data is conflicting. To bring logic into what often becomes a very emotional argument we must look at the limits to the body's tolerance for changes in the concentration and function of the varying components, the complications of massive blood transfusion, the true advantages of blood component therapy and in particular the myths and realities of fresh blood.
The rational use of blood has been discussed by Beal! who concludes that it is imperative that the best possible use be made of the limited supplies of a precious human resource. Component therapy involving the replacement of whole blood with red cell concentrates permits a more economical use of donated blood than has previously been achieved. This enthusiasm for blood component preservation has provided an impetus on the part of blood bankers to encourage the increased usage of packed red blood cells. The advantages of packed red blood cells have been questioned by Grindon. 2 The electrolyte abnormality of packed red blood cells is greater the longer the interval between preparation and administration. Ideally, preparation is performed immediately before administration but in order to prepare other components, packed cells must be separated immediately after collection. The recent introduction of rejuvenating solutions essentially overcomes this problem.
Fresh blood is generally regarded as anticoagulated whole blood with a limited storage lesion. This is ACD or CPD blood stored for less than 24 hours and containing adequate concentration of all components, in particular 2,3 diphosphoglyceric acid (2,3-DPG), platelets and the labile coagulation Factors V and VIII. Super-fresh blood is nonrefrigerated blood transfused within hours of Anaesthesia and Intensive Care, Vol. VIII, No. 2, May, 1980 collection. Stored whole blood can be substituted by component therapy and specific blood fractions are available for all recognised haemostatic defects. Controversy has surrounded the use of fresh blood in the massive blood loss-transfusion situation (vide infra). However, there is a strong feeling in clinical practice concerning the justification for the use of fresh blood. 3 • 4 One or more unidentified factors important in the control of haemostasis may be present in fresh blood and not in component therapy.
Management of massive blood loss
Blood loss following trauma has in the past been external but with the advent of the seat belt the majority of patients have gross loss of intravascular volume into the soft tissue department. Classically, this presents as gross pallor, tachycardia, sweating, hypotension, air hunger and anxiety or coma. Table 1 summarises a practical approach to the exsanguinated patient. It is essential that time is not wasted by the insertion of a central venous catheter or worse, a Swan-Ganz catheter. Initially, volume infusion and initial blood replacement is best via a large tapered cannula in a large vein. Immediate use of a MAST suit (Military Anti-Shock Trouser) will tamponade bleeding below the diaphragm, prevent further blood loss and reduce the size of the intravascular space. s An additional benefit is the autotransfusion of blood from the limbs to the central volume compartment. The use of the MAST suit is of proven value and is absolutely essential in the pre-hospital and inhospital care of major trauma,6.7 and it has been effectively used in bleeding arising from the upper gastrointestinal tract, obstetrical and gynaecological areas, the retroperitoneal space and the limbs.
Massive transfusion is that required to sustain the life of the exsanguinating patient. Any problems in the logistics of supply, whether it be donation, collection, distribution, storage, preservation or administration may be disastrous as may any deficiency in the blood product itself. Stored whole blood remains the only readily available form of red cells and volume. Due recognition must be given to the fact that during massive blood transfusion an exchange transfusion with storage damaged blood is being performed. Collins 8 mathematically analysed the dynamics of exchange transfusion. Under clinical circumstances there is little difference between incremental and continuous exchange methods of calculation. After one blood volume replacement there remains 30070 of the original blood volume and after two blood volume replacements there remains 10070 of the original blood volume. These guidelines are helpful in the interpretation of coagulation defects and other metabolic changes induced by trans fusion. 9 Effectiveness of blood transfusion is difficult to assess and it cannot be assumed that the correction of volume deficits in shock states will automatically reverse the subsequent lifethreatening physiological alterations set in motion by hypovolaemia. Shoemaker lo studied the ability of whole blood to optimise cardiorespiratory variables and showed the increase in oxygen availability to the tissues after blood transfusion. However, the increase in oxygen consumption by the non-survivors was only half that of the survivors.
Following initial volume restoration, haemorrhage control and clinical assessment, specific monitoring of volume replacement is indicated. Whilst invaluable information may be gained by the use of left heart pressure monitoring and cardiac output estimation, their use is restricted by lack of equipment and expertise. Their cost and small risk of complication do not justify their widespread use without specific indication. In most cases. adequate volume assessment is made on clinical grounds along with central venous pressure monitoring, repeated chest radiography and urine output measurement.
The importance of minimising transfusion cannot be over emphasised. 11 Transfusion requirements may be reduced by:
Autotransfusion has been considered with varying enthusiasm but logistic and inherent problems with the technique have prevented wider application. These include safe anticoagulation, adequate filtration, contamination, air embolism, coagulopathy and mechanical trauma to the blood components. However, it is used successfully as reviewed by Mattox 11 in cases of trauma, unusual blood types and in situations of a restricted supply of homologous blood.
Considering the reduced oxygen-carrying capacity of stored citrated cells and the fact that in initial resuscitation blood is often used solely as a volume replacement,12 mention should be made of methods of avoiding transfusion. There are many volume expanders (plasma protein fraction, albumin, dextran, gelatin, etc.) available which claim advantages including improved per fusion of the microcirculation, low incidence of side effects, economy, ease of storage and availability in time of national disaster. Controversy surrounds the use of colloids and crystalloids l ] and the incidence of reaction to the various replacement fluids. Haemaccel with a short half life (4 hours) and a 50070 intravascular distribution can be used in initial urgent resuscitation. Stable plasma protein solution (SPPS) has been associated with hypotension when infused rapidly. Dextrans remain within the circulation with a longer half life, 12 hours, have a greater volume expanding effect, reduce red blood cell aggregability and produce an antithrombotic effect. However, their use has been associated with an incidence of hypersensitivity. As plasma substitutes are unable to transport oxygen, haemoglobin solution has been a subject of investigation for many years. 14 It has advantages over both blood and plasma substitutes. As a component of normal blood, haemoglobin solution may be prepared from old blood, does not require crossmatching, transports oxygen, produces no microaggregation, possesses osmotic activity and has a lower viscosity than blood. However, it remains unsuitable for clinical use due to potential toxicity, poor oxygen delivery and insufficient intravascular retention caused by renal excretion. 15, 16 COMPLlCA nONS Of all the indications for transfusion therapy, massive blood transfusion is associated with the most potential hazards l7 ( Table 2) . Space permits only a superficial analysis of this controversial area.
Citrate toxicity
Citrate toxicity was one of the first complications of massive transfusion described and it remains an important clinical problem, the solution now being as ill defined as it was 50 years ago. The patient has two responses to citrate infusion; (i) the removal of citrate, (ii) the mobilisation of ionised calcium. Citrate is metabolised via the Krebs cycle in all nucleated body cells. The liver has the greatest activity per unit weight but due to its small mass is not the predominant site of removal. Citrate levels rise during transfusion and have been known since 1916 18 to become toxic at high rates of infusion. Marked elevation in citrate is seen with transfusion exceeding 500 mls in 5 minutes, this level falling rapidly on slowing the infusion. 8 Citrate metabolism is impaired by hypotension, hypothermia and liver disease, the greatest impairment being with hypotension. 19 Mobilisation of calcium depends on parathormone response which may diminish as stores are depleted, and mobilisation from bone, which is reduced under conditions of bone hypoperfusion. The clinical significance of minor depression of ionised calcium remains ill defined and it is accepted that a warm, wellperfused adult patient with normal liver function can tolerate a unit of blood each 5 minutes without requiring calcium. Common practice today is to administer 10070 calcium gluconate 1.0 g intravenously, following each 5 units of whole blood transfusion.
Altered haemoglobin function
Whole blood storage in citrate solutions results in altered haemoglobin function, the clinical significance of which has not yet been defined. 2o , 21 The concentrations of 2,3-DPG fall essentially to zero after 3 weeks in both ACD and CPD blood, the rate of decay being slower Anaesthesia and Intensive Care, Vol. VIlf, No. 2, May, 1980 for CPD than ACD. This reduction in 2,3-DPG increases the affinity of haemoglobin for oxygen, shifts the oxygen haemoglobin dissociation curve to the left, reduces the P50 and reduces oxygen delivery at tissue level.
It has been shown that at normal haematocrit concentrations there is little effect of depleting red cells of 2,3-DPG. However, it has been postulated that under conditions of deficiencies of the oxygen delivery system such as reduction in red cell mass, ventilation-per fusion inequality, intrapulmonary venoarterial shunting and impaired cardiac output, then 2,3-DPG depletion will be clinically significant, but this remains speculation. 22 
Haemostatic failure
The nature and management of the haemostatic defects in the massive blood losstransfusion situation is probably the least understood and most controversial aspect of the subject. 23 There has been a tendency to search for a single cause, but current evidence would indicate that it is multifactorial and therapy should be directed at all defects. There is a tendency to order numerous tests and to correct the worst abnormalities with component therapy. Table 3 lists the possible factors contributing to haemostatic failure. The diagnosis and importance of disseminated intravascular coagulation (DIC) in trauma may be difficult to determine. Many of the laboratory abnormalities found in DIC (e.g. elevated FDP's, ethanol gelation, thrombocytopenia and low anti-thrombin Ill) may be present but are difficult to interpret in the presence of trauma, shock and oliguria. There is some evidence that massive blood transfusion itself may contribute to DIC due to coagulant actIvIty from degenerate cells, stroma or activated coagulation factors. As a general rule it is rare that any specific therapy, such as heparin, need be used to control DIe. All efforts should be directed at resuscitation and management of the trauma. 24 ,25 The labile coagulation Factors V and VIII, not present in significant amounts of stored blood, are not adequately replaced during massive blood transfusion 26 and fresh frozen plasma should be infused if the partial thromboplastin time with kaolin (PTTK) or prothrombin time (PT) is prolonged. Superfresh blood in the massive blood losstransfusion situation is a controversial and emotive subject. Many blood bankers insist that all the patient's needs can be supplied by blood component therapy, whereas some clinicians advocate that super-fresh blood should be available for all massive blood transfusions. It must be acknowledged that super-fresh blood is the best way of providing all the blood components needed in extreme cases of exsanguination and when more than 10 units of stored blood have been transfused. On these grounds alone it is probably desirable to have collection facilities available near all major trauma centres.
Thrombocytopenia is a consistent feature following massive blood transfusion and, as with the coagulation defects, loss, consumption, dilution and reduced production are all contributory. Some workers feel strongly that platelet concentrates should be usedY However, each unit of super-fresh blood provides the equivalent of two platelet concentrates, further supporting the case for fresh blood after 10 units of stored blood have been transfused. Using this approach all the necessary components are provided but the patient is exposed to a smaller donor pool, thus reducing the antigenic load and risk of hepatitis.
In conclusion, the haemostatic defect and its management remains controversial. Unless initial resuscitation is rapid and effective the patient is likely to enter a vicious circle resulting in advanced failure of haemostasis. Recently interest has also been shown in the inhibitors which control coagulation and platelet function (e.g. antithrombin HI and prostacyclin) and there is suggestive evidence that, despite adequate coagulation factor replacement therapy, these inhibitors may be needed to 'switch off' the haemostatic system and stop the vicious circle of transfusion--' consumption--' depletion--' bleeding.
Much as one would like to have 'rules of thumb' to assist in the therapy of haemostatic failure these cannot be set up to cover all eventualities. In many settings where blood loss occurs there may be minimal laboratory facilities available and decisions are essentially empirical.
Acid-base alteration and electrolyte disturbances
Stored bank blood contains an appreciable acid load and is often used in a situation of preexisting and continuing metabolic acidosis. 28 The excess acidity of stored blood is due mainly to the citric acid of the anticoagulant and the lactic acid generated during storage. These intermediary metabolites are rapidly metabolised in states of adequate tissue perfusion, the end result being a metabolic alkalosis. Hence, the routine use of alkali is mostly unnecessary and is generally contraindicated. Alkalaemia further shifts the oxyhaemoglobin dissociation curve to the left, provides a large additional sodium load to a patient whose ability to handle salt and water is impaired and depresses the return of ionised calcium to normal following citrate infusion. Acid-base estimations must be performed and corrected in the context of the clinical situation. With continuing hypoperfusion it is to be expected that metabolism of citrate and lactate will be deficient, lactic acidosis production will continue, and there may be an indication for acidosis correction with alkali and low ionised calcium correction with intravenous calcium.
Serum potassium has been a controversial area for many years and it is unlikely that the high serum potassium levels observed in stored blood cause any pathological effects, with the possible exception of acute renal failure. However, hypokalaemia may be a problem 24 hours after transfusion as the large number of transfused red cells correct their electrolyte composition and potassium returns into the cells.
Hypothermia
Blood warmed from 4 0 to 37°C requires 300 kcal, the equivalent heat produced by one hour muscular work with an oxygen requirement of 62 litres of oxygen. 8 Hypothermia impairs the metabolism of citrate and lactate, shifts the oxyhaemoglobin dissociation curve to the left, increases intracellular potassium release, impairs red cell deformability, delays drug metabolism, masks clinical signs, increases the incidence of arrhythmias and reduces cardiac output. Jaundice Jaundice is common following massive blood transfusion and there may be several contributing factors which have to be considered. Accepting that an average of 30070 of stored blood may not survive following transfusion the patient is burdened with a considerable load of bilirubin. During hypovolaemia and shock, liver function is impaired. A cholestatic picture is most commonly seen, particularly in infected patients. There is evidence to suggest that these patients may be able to conjugage the bilirubin but there is an impairment in transport on the conjugated bilirubin into the bile canaliculi. The effect of resorbing haematoma should also be remembered.
Microaggregates
The subject has been discussed in detail by Dr. Loong but it should be emphasised that, although the pathological effects of microaggregates are still controversial, massive and rapid blood transfusion must, if any, be the indication par excellence for the use of micro filters .
Crossmatching difficulties
Due to the exchange transfusion that results in the massive blood transfusion situation a valid crossmatch becomes difficult to perform as the circulating plasma does not represent that of the patient. Occasionally large volumes of plasma substitutes may interfere with cross matching techniques, especially if an enzyme method is used.
